TABLE 2.

Total stool volume versus day 10 vibriocidal antibody titer and total stool volume versus fold increase in vibriocidal antibody titer from day 0 to day 10 in each treatment group

Assessment	Vaccine group		Placebo group
	No. of subjects	Mean (median) total stool volume (liters)	No. of subjects	Mean (median) total stool volume (liters)
Day 10 vibriocidal antibody titer
20–80	5	7.1 (3.9)	46	6.2 (5.4)
160–640	6	2.5 (0.7)	15	3.3 (2.2)
1,280–2,560	11	0.4 (0.2)	4	2.5 (2.2)
5,120–10,240	33	0.1 (0.0)	1	0.1 (0.1)
20,480–81,920	13	0.1 (0.0)	0
Fold increase in vibriocidal antibody titer from day 0 to day 10
≤2	6	7.1 (6.8)	65	5.3 (4.4)
4–8	4	2.2 (2.5)	0
16–32	12	0.1 (0.0)	1	0.0 (0.0)
64–128	18	0.2 (0.0)	0
256–512	18	0.1 (0.0)	0
1,024–4,096	10	0.1 (0.0)	0